Back
Biogen Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
35
BIIB
Biogen
Last Price:
222.75
Seasonality Move:
8.55%
Sell
49
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
43.15
Seasonality Move:
-11.02%
Sell
35
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $223.18. The Score for BIIB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $44.30. The Score for CRBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $44.30
The current trend is moderately bearish and CRBP is experiencing slight selling pressure.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 47.61 | Sell |
| Chaikin Money Flow: | -549910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (220.69 - 231.63) | Sell |
| Bollinger Bands (100): | (207.84 - 232.4) | Buy |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 49.14 | Sell |
| Chaikin Money Flow: | -68505 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.41 - 48.51) | Sell |
| Bollinger Bands (100): | (30.43 - 45.69) | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 226.85 | Sell |
| 20-day SMA: | 226.68 | Sell |
| 50-day SMA: | 219.08 | Buy |
| 200-day SMA: | 234.42 | Sell |
| 8-day EMA: | 225.84 | Sell |
| 20-day EMA: | 225.95 | Sell |
| 50-day EMA: | 223.07 | Buy |
| 200-day EMA: | 234.15 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.47 | Sell |
| 20-day SMA: | 45.57 | Sell |
| 50-day SMA: | 42.55 | Buy |
| 200-day SMA: | 22.33 | Buy |
| 8-day EMA: | 44.69 | Sell |
| 20-day EMA: | 45.06 | Sell |
| 50-day EMA: | 42.58 | Buy |
| 200-day EMA: | 27.79 | Buy |
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.13 per share, an increase this year of $0.64 per share, and an increase next year of $1.59 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.55 per share, an increase next quarter of $0.28 per share, an increase this year of $5.53 per share, and an increase next year of $0.35 per share.
Biogen Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||